04 October 2019 – BBC News
Pre-exposure prophylaxis (PrEP) is a tablet administered daily which can stop a person from getting HIV.
England is the only place in the UK where places on a trial to access the drug through the NHS are restricted.
The Department of Health said plans are under way for “routine commissioning” when the trial ends next year.
At least 15 men have been diagnosed with HIV whilst waiting for the trial.